Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PMK BioResearch
- Ownership
- Private
- Development stage
- Other
01
Overview
PMK BioResearch is a life sciences consulting business founded by oncologist and biotech executive Dr. Pamela M. Klein in 2008. The firm provides strategic and advisory consulting to biotechnology companies, corporate boards, management teams, investors, and venture firms, with a particular emphasis on oncology drug development. Available public descriptions position the company as an independent advisory practice rather than a therapeutic-product developer, CRO, or sponsor with an internal clinical pipeline. PMK BioResearch appears to support strategy, clinical development, and portfolio decision-making across biotech stages rather than commercializing its own drugs.
- Therapeutic areas
- Oncology
- Industry
- Consulting
Beyond the preview
Go deeper on PMK BioResearch.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on PMK BioResearch.